Skip to main content
Caplight Logo









AltrixBio Inc.

AltrixBio Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.altrixbio.com/

Last Round

Series A

Sep 16, 2025

Total Funding Raised

$6.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AltrixBio Inc. is a biotechnology company that develops non-systemic oral therapies designed to replicate the metabolic benefits of bariatric surgery for the treatment of type 2 diabetes and obesity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

non-systemic therapybariatric surgery in a pillobesity treatmenttype 2 diabetes treatmentGLP-1 alternativeoral obesity treatmentbariatric surgery alternativegut-restricted therapyluminal coatingweight loss druganti-obesity medicationAOMcardiometabolic therapyclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AltrixBio Inc. Comparables

Compare AltrixBio Inc. with similar companies based on industry and business-model similarity.

AltrixBio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Syntis Bio, Inc.
93%
Glyscend Therapeutics
91%
Kallyope
79%

AltrixBio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 16, 2025
SeedNov 6, 2020

Key People

Founding team and executive leadership

David Pass

President and Chief Executive Officer

Executive Team

AltrixBio Inc. Investors

Notable investors and investment history

AltrixBio Inc. investors
InvestorRounds
Arizona Tech InvestorsSeed
Taihill VentureSeed
MIT Alumni AngelsSeed
XFactor VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 33% MoM.

  • May 16, 2026

    Monthly visitors increased 43% MoM.

AltrixBio Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AltrixBio Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AltrixBio Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range7
Year Founded2019
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?